Vision Research in Europe

Vision and Physiological Optics Conference in Athens 2018

Report on the 9th European edition of the Vision and Physiological Optics Conference took place in Athens from the 29th to the 31st of August.
» Vision and Physiological Optics Conference in Athens 2018

Gene therapy breakthrough wins world's largest vision award

Seven scientists in the United States and Britain who have come up with a revolutionary gene therapy cure for a rare genetic form of childhood blindness won a 1 million Euro. The 2018 António Champalimaud Vision Award winners, who have transformed medical care with their work, are: Jean Bennett,...
» Gene therapy breakthrough wins world's largest vision award

Researchers reverse congenital blindness in mice

Researchers funded by the National Eye Institute (NEI) have reversed congenital blindness in mice by changing supportive cells in the retina called Müller glia into rod photoreceptors. The findings advance efforts toward regenerative therapies for blinding diseases such as age-related macular...
» Researchers reverse congenital blindness in mice

Artificial intelligence equal to experts in detecting eye diseases

An artificial intelligence (AI) system, which can recommend the correct referral decision for more than 50 eye diseases, as accurately as experts has been developed by Moorfields Eye Hospital NHS Foundation Trust, DeepMind Health and UCL.
» Artificial intelligence equal to experts in detecting eye diseases

Wills Eye Sponsors First U.S. Study of Device for Blind Retinitis Pigmentosa Patients

Wills Eye Hospital has been given Food and Drug Administration (FDA) approval to begin an early feasibility study (EFS) to implant the RETINA IMPLANT Alpha AMS sub-retinal device in patients blind due to Retinitis Pigmentosa (RP).
» Wills Eye Sponsors First U.S. Study of Device for Blind Retinitis Pigmentosa Patients

Grant adressing the Optimal Treatment Approach to Sub-Macular Haemorrhage

In collaboration with Fight for Sight, EURETINA have launched a call for applications for clinical research to address the best treatment option for Sub-Macular Haemorrhage caused by Age-Related Macular Degeneration.
» Grant adressing the Optimal Treatment Approach to Sub-Macular Haemorrhage

Visionary of the Quarter

Young Researcher in Focus

Read more about Helen May-Simera and her work in the field of vision research.

Latest News

AGTC Earns $10 Million After Reaching Phase I/II Study Milestone

Applied Genetic Technologies Corporation has... Read more

Injection of vasoactive intestinal peptide into the eye improves corneal transplant survival

A new study in the American Journal of Pathology... Read more

High-profile journals put to reproducibility test

Researchers replicated 62% of social-behaviour... Read more

Doctors remove contact lens embedded in eyelid for years

Doctors recently removed a contact lens that was... Read more

£3.5-million grant lost

Top geneticist loses £3.5-million grant in first... Read more

Retinal abnormalities may indicate preclinical Alzheimer's

Retinal microvascular abnormalities are identified... Read more

Dompe’s Oxervate is First Treatment Approved in US for Neurotrophic Keratitis

Oxervate is the first US treatment for this... Read more

INSiGHT identifies unique retinal regulatory genes

Researches at Baylor College of Medicine, Texas... Read more

Massive £30-million grant will be awarded to one cardiovascular research team

British Heart Foundation award is one of the... Read more

What role do immune cells play in dry eye?

Immune cells that disrupt the ability of eyelid... Read more